2017
DOI: 10.1136/bmjopen-2017-019317
|View full text |Cite
|
Sign up to set email alerts
|

Protocol for the ROBUST (Registry Of type B aortic dissection with the Utility of STent graft) study: an ambispective, multicentre, open cohort study

Abstract: IntroductionThoracic endovascular aortic repair (TEVAR) is widely used for type B aortic dissection, although with satisfactory outcome in a limited proportion of patients. To better inform patient prognostication, the Registry Of type B aortic dissection with the Utility of STent graft (ROBUST) study aims to identify imaging-based predictors of post-TEVAR adverse outcomes up to 10-year follow-up.Methods and analysisROBUST is designed as an ambispective, multicentre, open cohort study. All patients undergoing … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…The study was registered with the Chinese Clinical Trials Registry (ChiCTR-POC-17011726), and the protocol for the ROBUST study was previously published. 18 In the ambispective ROBUST study design, patients with TBAD managed by TEVAR were retrospectively enrolled from 1 January 2008 to 31 December 2016; prospective enrollment began in 1 January 2017 and will continue to 31 December 2027. The 254 retrospectively enrolled patients were candidates for the current analysis.…”
Section: Study Populationmentioning
confidence: 99%
“…The study was registered with the Chinese Clinical Trials Registry (ChiCTR-POC-17011726), and the protocol for the ROBUST study was previously published. 18 In the ambispective ROBUST study design, patients with TBAD managed by TEVAR were retrospectively enrolled from 1 January 2008 to 31 December 2016; prospective enrollment began in 1 January 2017 and will continue to 31 December 2027. The 254 retrospectively enrolled patients were candidates for the current analysis.…”
Section: Study Populationmentioning
confidence: 99%
“…All patients enrolled in this retrospective study were derived from the ROBUST (Registry Of type B aortic dissection with the Utility of STent graft) study, which is a multicenter, open study (ChiCTR-POC-17011726) that focuses on the adverse events after TEVAR. Further, it was conducted at four different medical centers in China (Chinese PLA General Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, Zhongshan People's Hospital, and Henan Provincial Chest Hospital) [12]. In total, 228 patients were identi ed from the ROBUST study.…”
Section: Patientsmentioning
confidence: 99%
“…The details of the ROBUST study have been previously described. 8 The ROBUST study was approved by the Institutional Review Board of each participating center and was conducted in compliance with the Declaration of Helsinki. Each Institutional Review Board waived the need for consent from patients whose data were retrospectively reviewed.…”
Section: Study Populationmentioning
confidence: 99%